Search

everythinglearnresearchcommunity

for

Search:↓

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Hair loss in women not always linked to increased oil production; other factors may be involved.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Use "female pattern hair loss" term, finasteride may help, more research needed.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Spironolactone may help enlarge a small breast linked to Becker's nevus.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Finasteride safely reduces excessive hair growth in women.

Male hormones worsen kidney transplant damage, but blocking them helps.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Finasteride improves hidradenitis suppurativa in children with no adverse effects.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Obesity is linked to various skin disorders, which can help with early diagnosis and prevention of long-term health issues.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.